Cour, M;
Pedretti, S;
Nduhirabandi, F;
Hacking, D;
Frias, MA;
Hausenloy, DJ;
Lecour, S;
(2024)
Interplay between the SAFE and the sphingolipid pathway for cardioprotection.
Life Sciences
, 358
, Article 123145. 10.1016/j.lfs.2024.123145.
![]() |
Text
LFS-D-24-05896_R2.pdf - Accepted Version Access restricted to UCL open access staff until 18 October 2025. Download (4MB) |
Abstract
Aim: Activation of both the Survivor Activating Factor Enhancement (SAFE) pathway (including Tumor Necrosis Factor-alpha (TNF-α) and Signal Transducer and Activator of Transcription-3 (STAT-3)) and the sphingolipid signalling pathway (including sphingosine kinase-1 (SK1) and sphingosine-1 phosphate (S1P)) play a key role in promoting cardioprotection against ischemia-reperfusion injury (IRI). We investigated whether the activation of the SAFE pathway by exogenous S1P is dependent on the activation of SK1 for cardioprotection. Materials and methods: Isolated cardiomyocytes from TNF-α knockout (KO) mice, cardiomyocyte-specific STAT-3 KO mice and their wild-type (WT) littermates were exposed to simulated ischemia in the presence of a trigger of the SAFE pathway (S1P) and SK1 inhibitor (SK1-I). Similarly, isolated perfused hearts from adult TNF-α KO, STAT-3 KO and WT mice were subjected to IRI with S1P and/or SK1-I. Cell viability, infarct size (IS) and SK1 activity were assessed. Key findings: In isolated cardiomyocytes and in isolated hearts subjected to simulated ischemia/IRI, S1P pretreatment decreased cell death in WT mice, an effect that was abrogated in the presence of SK1-I. S1P failed to reduce cell death after simulated ischemia/IRI in both cardiomyocytes or hearts isolated from TNF-α KO and STAT-3 KO mice. Interestingly, S1P pretreatment increased SK1 activity in WT and STAT-3 KO mice, with no changes in TNF-α KO mice. Significance: Our data strongly suggest SK1 as a key component to activate STAT-3 downstream of TNF-α in the SAFE pathway, paving the way for the development of novel cardioprotective strategies that may target SK1 to modulate the SAFE pathway and increase cell survival following IRI.
Type: | Article |
---|---|
Title: | Interplay between the SAFE and the sphingolipid pathway for cardioprotection |
Location: | Netherlands |
DOI: | 10.1016/j.lfs.2024.123145 |
Publisher version: | http://dx.doi.org/10.1016/j.lfs.2024.123145 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Ischemia-reperfusion injury, Mitochondria, Signal transducer and activator of transcription 3, Sphingolipid, Survivor activating factor enhancement pathway, Tumor necrosis factor alpha |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10200280 |
Archive Staff Only
![]() |
View Item |